Clinical Trial Update: Evaluation of Efficacy and Safety of Immune Check Point Inhibitors in Hepatocellular Carcinoma Patients in Ain Shams University Hospitals

View source ↗

Summary

A clinical trial update from Ain Shams University Hospitals indicates enrollment of hepatocellular carcinoma patients to evaluate the efficacy and safety of imm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)
• Durvalumab (durvalumab)

Snippet

Sponsor: Ain Shams University | Conditions: HCC - Hepatocellular Carcinoma, Immunotherapy | Status: ENROLLING_BY_INVITATION